| # | Title | Journal | Year | Citations |
|---|
| 1 | The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation | Atherosclerosis | 2015 | 587 |
| 2 | The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis | Journal of Clinical Endocrinology and Metabolism | 2009 | 518 |
| 3 | Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel | Archives of Medical Science | 2015 | 311 |
| 4 | The Relation Between Atherosclerosis and the Neutrophil–Lymphocyte Ratio | Clinical and Applied Thrombosis/Hemostasis | 2016 | 271 |
| 5 | Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel | Nutrition Reviews | 2017 | 238 |
| 6 | Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS Study | Journal of Psychosomatic Research | 2010 | 217 |
| 7 | The Role of Nutraceuticals in Statin Intolerant Patients | Journal of the American College of Cardiology | 2018 | 216 |
| 8 | The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement | Metabolism: Clinical and Experimental | 2017 | 208 |
| 9 | Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials | Journal of the American Heart Association | 2016 | 207 |
| 10 | Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel | Archives of Medical Science | 2017 | 206 |
| 11 | Leptin, cardiovascular diseases and type 2 diabetes mellitus | Acta Pharmacologica Sinica | 2018 | 197 |
| 12 | Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease? | Progress in Lipid Research | 2012 | 187 |
| 13 | Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies | BMC Medicine | 2015 | 169 |
| 14 | The role of Toll-like receptors in renal diseases | Nature Reviews Nephrology | 2010 | 168 |
| 15 | Effects of Coenzyme Q10 on Statin-Induced Myopathy | Mayo Clinic Proceedings | 2015 | 168 |
| 16 | Endocan: A novel inflammatory indicator in cardiovascular disease? | Atherosclerosis | 2015 | 159 |
| 17 | Lipid-modifying effects of nutraceuticals: An evidence-based approach | Nutrition | 2016 | 157 |
| 18 | Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients | International Journal of Cardiology | 2015 | 154 |
| 19 | Prevalence of statin intolerance: a meta-analysis | European Heart Journal | 2022 | 151 |
| 20 | Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials | Pharmacological Research | 2015 | 145 |
| 21 | Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms | Atherosclerosis | 2016 | 142 |
| 22 | Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials | Atherosclerosis | 2015 | 139 |
| 23 | Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials | International Journal of Cardiology | 2015 | 138 |
| 24 | How safe is the use of thiazolidinediones in clinical practice? | Expert Opinion on Drug Safety | 2009 | 136 |
| 25 | A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations | Scientific Reports | 2015 | 133 |
| 26 | Arterial Stiffness in the Heart Disease of CKD | Journal of the American Society of Nephrology: JASN | 2019 | 128 |
| 27 | Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel | Expert Opinion on Drug Safety | 2015 | 117 |
| 28 | Peroxynitrite and Brain Mitochondria: Evidence for Increased Proton Leak | Journal of Neurochemistry | 1998 | 110 |
| 29 | Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies | European Heart Journal | 2019 | 103 |
| 30 | Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance | Journal of Diabetes and Its Complications | 2018 | 97 |
| 31 | Contrast-Induced Nephropathy | Angiology | 2015 | 96 |
| 32 | Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population | Current Medical Research and Opinion | 2010 | 93 |
| 33 | Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—A meta-analysis of 11 randomized controlled trials involving 21,295 participants | Pharmacological Research | 2013 | 90 |
| 34 | Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials | Pharmacological Research | 2019 | 90 |
| 35 | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | Current Vascular Pharmacology | 2018 | 87 |
| 36 | The mechanisms of atrial fibrillation in hyperthyroidism | Thyroid Research | 2009 | 85 |
| 37 | Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions | Journal of Cachexia, Sarcopenia and Muscle | 2018 | 84 |
| 38 | Takotsubo cardiomyopathy — The current state of knowledge | International Journal of Cardiology | 2010 | 78 |
| 39 | Dietary inflammatory index and cardiometabolic risk in US adults | Atherosclerosis | 2018 | 78 |
| 40 | The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP) | Clinical Nutrition | 2021 | 75 |
| 41 | Metabolic syndrome and renal disease | International Journal of Cardiology | 2013 | 74 |
| 42 | Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic | Archives of Medical Science | 2020 | 70 |
| 43 | Alterations in the High Density Lipoprotein Phenotype and HDL‐Associated Enzymes in Subjects with Metabolic Syndrome | Lipids | 2009 | 69 |
| 44 | Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate | BMC Medicine | 2016 | 68 |
| 45 | Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box! | Metabolism: Clinical and Experimental | 2019 | 67 |
| 46 | A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? | International Journal of Cardiology | 2013 | 66 |
| 47 | The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia | Current Medical Research and Opinion | 2008 | 65 |
| 48 | Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Drugs | 2018 | 64 |
| 49 | Effects of selected dietary constituents on high-sensitivity C-reactive protein levels in U.S. adults | Annals of Medicine | 2018 | 63 |
| 50 | Does Diabetes Mellitus Play a Role in Restenosis and Patency Rates Following Lower Extremity Peripheral Arterial Revascularization? A Critical Overview | Annals of Vascular Surgery | 2008 | 61 |
